Here are some of the top stories in healthcare, telemedicine, and mobile health that our sister site mHealthWatch been monitoring in recent days.
On Monday, the U.S. Food and Drug Administration (FDA) issued its long awaited final guidance for developers of mobile medical applications. As expected, the guidance outlines the FDA’s tailored approach to mobile apps.
Pharmacists in the state of Oregon are lobbying state lawmakers to allow e-prescribing of schedule II drugs. Until now, Oregon has been “behind the curve” when it comes to the electronic prescribing of various controlled substances. But with common physical injuries resulting in a need for such common drugs as Oxycontin and Adderall, it no longer seems purposeful to require a time-consuming and inefficient mandatory paper prescription for these and other drugs.
There’s nothing quite like a comprehensive report on the growth of the mHealth market to really get the blood pumping. This week, “The Mobile Healthcare (mHealth) Bible: 2014 – 2020” was published, revealing a multitude of opportunities for the pharmaceutical industry thanks to the emerging technologies of our time. Despite barriers relating to regulation, patient acceptance and privacy concerns, research estimates further growth at a CAGR of nearly 40% over the next 6 years.
The Health Information Technology for Economic and Clinical Health (HITECH) Act sought to improve American health care delivery and patient care through an unprecedented investment in health information technology (health IT) and adoption of electronic health records (EHRs). So how has the nation progressed since passage of the HITECH Act of 2009? A new infographic from HealthIT.gov puts the progress into perspective.
MHW learned Tuesday that registration has now begun for the 2013 mHealth Summit. This year’s event will be held December 8-11, 2013 at the Gaylord National Harbor Convention Center, in the Washington, D.C. area.